Phase 3 Study to Assess Resiniferatoxin vs Standard of Care for the Treatment of Intractable Cancer Pain

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
This is a Phase 3 study to assess the safety and efficacy of a single epidural administration of Resiniferatoxin versus standard of care for the treatment of intractable pain associated with cancer.
Epistemonikos ID: 4801913eb15d2d30f0a6e6c5b8397e423143b690
First added on: May 07, 2024